|
Nectar Lifesciences Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
381.02 Cr.
|
P/BV
|
0.40
|
Book Value (Rs.)
|
42.63
|
|
52 Week High/Low (Rs.)
|
44/13
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
21/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | -5.07 | 0.22 | -1.08 | 1.12 | -3.27 |
| Diluted EPS (Rs.) | -5.07 | 0.22 | -1.08 | 1.12 | -3.27 |
| Cash EPS (Rs.) | -2.29 | 2.93 | 1.56 | 3.66 | -0.58 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 42.63 | 47.68 | 47.47 | 48.51 | 47.36 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 42.63 | 47.68 | 47.47 | 48.51 | 47.36 |
| Revenue From Operations / Share (Rs.) | 74.47 | 75.10 | 67.94 | 74.42 | 68.82 |
| PBDIT / Share (Rs.) | -1.10 | 7.41 | 4.29 | 7.57 | 5.03 |
| PBIT / Share (Rs.) | -3.88 | 4.70 | 1.65 | 5.03 | 2.34 |
| PBT / Share (Rs.) | -7.20 | 0.81 | -1.89 | 1.52 | -3.78 |
| Net Profit / Share (Rs.) | -5.07 | 0.22 | -1.08 | 1.12 | -3.27 |
| NP After MI And SOA / Share (Rs.) | -5.07 | 0.22 | -1.08 | 1.12 | -3.27 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | -1.47 | 9.86 | 6.31 | 10.17 | 7.31 |
| PBIT Margin (%) | -5.20 | 6.25 | 2.43 | 6.76 | 3.40 |
| PBT Margin (%) | -9.67 | 1.08 | -2.78 | 2.04 | -5.49 |
| Net Profit Margin (%) | -6.80 | 0.29 | -1.58 | 1.50 | -4.74 |
| NP After MI And SOA Margin (%) | -6.80 | 0.29 | -1.58 | 1.50 | -4.74 |
| Return on Networth / Equity (%) | -11.88 | 0.46 | -2.27 | 2.30 | -6.89 |
| Return on Capital Employeed (%) | -8.47 | 8.65 | 2.85 | 8.13 | 4.09 |
| Return On Assets (%) | -5.55 | 0.22 | -1.10 | 1.04 | -2.96 |
| Long Term Debt / Equity (X) | 0.06 | 0.13 | 0.21 | 0.26 | 0.12 |
| Total Debt / Equity (X) | 0.60 | 0.59 | 0.70 | 0.79 | 0.79 |
| Asset Turnover Ratio (%) | 0.78 | 0.76 | 0.66 | 0.68 | 0.60 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.26 | 1.50 | 1.59 | 1.56 | 1.04 |
| Quick Ratio (X) | 0.53 | 0.59 | 0.62 | 0.69 | 0.54 |
| Inventory Turnover Ratio (X) | 2.05 | 1.42 | 1.39 | 1.65 | 1.13 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | -1.53 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | -8.61 |
| Earning Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 101.53 |
| Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 108.61 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | -0.32 | 1.91 | 1.21 | 2.16 | 1.01 |
| Interest Coverage Ratio (Post Tax) (%) | -0.52 | 1.06 | 0.69 | 1.32 | 0.57 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 1078.15 | 1290.98 | 1091.93 | 1381.46 | 1231.83 |
| EV / Net Operating Revenue (X) | 0.64 | 0.76 | 0.71 | 0.82 | 0.79 |
| EV / EBITDA (X) | -43.89 | 7.77 | 11.35 | 8.13 | 10.92 |
| MarketCap / Net Operating Revenue (X) | 0.30 | 0.40 | 0.23 | 0.32 | 0.27 |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 101.53 |
| Price / BV (X) | 0.53 | 0.63 | 0.33 | 0.49 | 0.39 |
| Price / Net Operating Revenue (X) | 0.30 | 0.40 | 0.23 | 0.32 | 0.27 |
| EarningsYield | -0.22 | 0.01 | -0.06 | 0.04 | -0.17 |
